THE LATEST WORD

Top Industry Stories – October 12, 2009

Posted on October 12th, 2009 | by Rxmedyn | No Comments »

Influence Of Doctor/Pharma Relationships On Prescribing Habits May Be Next Big Congressional Inquiry; Sunshine Act Could Be Investigation Boon (The Pink Sheet)

 This is copyright protected information, to receive the full article, please click here to sign up and register.

Ahead of the Bell: Pharma Product Development Inc (CNBC/Associated  Press)

Selzentry Patient Population Needs Further Definition, Advisory Panel Urges (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Omeros Debuts With $68 Million IPO Despite Legal Hassles From Former CFO (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S. (Press release issued by CSL Behring)

Ex-biotech exec gets 3 years for faking cancer (Lake Wylie Pilot)

Celator(R) Pharmaceuticals Completes Enrollment Early in Phase 2 Study of CPX-351 in Newly Diagnosed AML (Press release issued by Celator Pharmaceuticals)

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza (The Medical News)

Orion Genomics enters collaboration and license agreement with Novartis Pharma (The Medical News)

Leave a Reply

You must be logged in to post a comment.